Landmark analysis of the risk of recurrence after resection or ablation for HCC: A nationwide study.

Frederik Kraglund Nikolaj Skou Gerda Elisabeth Villadsen Prof Peter Jepsen

Published in: Hepatology communications (2024)

In conclusion, the risk of recurrence or death following resection or ablation for HCC is high from the treatment date, but the risk of recurrence decreases greatly over the survival landmarks. This information is valuable for clinicians and their patients.

Keyphrases

end stage renal disease
free survival
ejection fraction
chronic kidney disease
palliative care
peritoneal dialysis
patient reported outcomes
catheter ablation